Life Sciences Returning To Pre-Pandemic Norms, CBRE Finds
Life sciences construction costs have skyrocketed since the onset of the pandemic, attributable to inflation pressure, rising costs for specialty equipment and growing lead times for equipment shipped from overseas, per...To view the full article, register now.
Already a subscriber? Click here to view full article